- Home
- TNGX
as 05-09-2025 12:45pm EST
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.
Upcoming Earnings Alert:
Get ready for potential market movements as Tango Therapeutics Inc. TNGX prepares to release earnings report on 12 May 2025.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | BOSTON |
| Market Cap: | 317.4M | IPO Year: | N/A |
| Target Price: | $12.33 | AVG Volume (30 days): | 542.7K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.19 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.11 - $12.02 | Next Earning Date: | 05-12-2025 |
| Revenue: | $42,069,000 | Revenue Growth: | 15.17% |
| Revenue Growth (this year): | -29.11% | Revenue Growth (next year): | -14.37% |
Latest Tango Therapeutics Inc. News
TNGX Breaking Stock News: Dive into TNGX Ticker-Specific Updates for Smart Investing
GuruFocus.com
4 hours ago
Tango Therapeutics Inc (TNGX) Q1 2025 Earnings Report Preview: What To Look For
GlobeNewswire
8 days ago
Tango Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025
GlobeNewswire
a month ago
Tango Therapeutics to Highlight Preclinical Data on Precision Oncology Pipeline with Five Posters at the American Association for Cancer Research (AACR) Annual Meeting 2025
Simply Wall St.
2 months ago
Tango Therapeutics Full Year 2024 Earnings: Revenues Disappoint
GlobeNewswire
2 months ago
Tango Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Highlights
GlobeNewswire
3 months ago
Tango Therapeutics to Present at Three Upcoming Investment Bank Conferences
Simply Wall St.
3 months ago
One Tango Therapeutics Insider Raised Stake By 400% In Previous Year
GlobeNewswire
3 months ago
Tango Therapeutics to Present at the Guggenheim SMID Cap Biotechnology Conference
Compare TNGX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TNGX Tango Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.